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Summary Severe liver disease due to Schistosoma mekongi was frequent in northern Cam-
bodia. Between 1995 and 2002, seven rounds of mass chemotherapy (praziquantel) reduced
infection from 50% to below 3%. In 2002, we assessed hepatosplenic morbidity by histori-
cal, clinical and ultrasonographic investigations in adults (older than 14 years) from endemic
(n = 342) and non-endemic (n = 103) areas (Kratie province). Clinical hepatomegaly (25 vs. 0%),
splenomegaly (55 vs. 0%), reported blood in stool (41 vs. 20%) and abdominal pain (78 vs. 57%)
were signiﬁcantly higher in the endemic area. In this area, signiﬁcantly more subjects reported
a family history of death due to schistosomiasis (12 vs. 0%); 63% (vs. 0%) reported having at
least three treatments of praziquantel in previous years; and only 11% (vs. 99%) had normal
liver ultrasonographic examination. Periportal ﬁbrosis with portal hypertension was diagnosed
in 46% (vs. 0%) of people in this area; 18% (vs. 0%) and 5% (vs. 0%) of portal hypertension was
classiﬁed as moderate and severe, respectively. People aged between 24 and 35 years were
mostly affected. There was no gender difference. The pathology in the endemic district is most
probably residual morbidity of S. mekongi infections. Contributions of co-infections (hepatitis)
cannot be excluded. Careful monitoring of the affected communities is required.
© 2007 Royal Society of Tropica
reserved.
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. Introductionchistosoma mekongi infection may lead to severe intesti-
al, hepatosplenic and cerebral morbidity. Mortality due
o this parasite was shown to be dramatic in non-treated
ransmission areas (Biays et al., 1999; Urbani et al., 2002),
ccurring mostly through oesophageal bleeding. Recently, a
e and Hygiene. Published by Elsevier Ltd. All rights reserved.
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ase of cerebral infection has been described (Houston et
l., 2004).
In 1968, the ﬁrst cases of S. mekongi originating from
ratie, Cambodia, were diagnosed (Audebaud et al., 1968;
ournier-Lasserve et al., 1970). In the subsequent period of
ar and political instability, follow-up ﬁeld investigations in
he province of Kratie were not possible. Ongoing transmis-
ion led to a high degree of morbidity and mortality in the
istricts of Sambo and Kratie, situated in the northern part
f Kratie province.
In 1994, approximately 10 patients with severe schis-
osomiasis were hospitalized each month in the district
ospital of Sambo and more than 150 affected patients
ere treated in the outpatient clinic (Biays et al., 1999).
he clinical picture of the severe cases included advanced
epatosplenomegaly, ascites and other signs of portal
ypertension. Death due to spleen rupture or oesophageal
leeding was frequently observed in Sambo District Hospital
nd Kratie Provincial Hospital and was often reported from
he communities.
In 1995, the entire population of three villages of Sambo
istrict (Samerong, Chatnaol and Achen) was examined.
orty-nine per cent were clinically diagnosed with hep-
tomegaly, reaching as high as 90% in children aged 10—14
ears and 60% in young adults aged 15—19 years (Stich et al.,
999). In addition, in a sample from 20 primary schools in
he districts of Sambo and Kratie, the prevalence of infec-
ion and hepatomegaly in school children reached 70 and
0%, respectively (Stich et al., 1999).
In the same year, a control programme based on annual
hemotherapy was started. The intervention targeted the
chistosomiasis-endemic districts of Sambo and Kratie pop-
lated by approximately 60 000 people. Up to 2002, seven
nnual mass drug administration campaigns were carried
ut in which all individuals (except children <2 years and
regnant women) were treated with praziquantel (40mg/kg
ody weight) in combination with mebendazole (500mg).
he annual coverage of treatment was between 62 and 74%
Sinuon et al., 2007).
Over the control programme period, between 1995 and
002, monitoring surveys showed that liver and intestinal
orbidity was reduced. Clinical manifestations, such as
epatomegaly and splenomegaly, and/or reports of blood
nd mucus in stool have been drastically reduced in
choolchildren in four sentinel villages, between 1995 and
002, as have the numbers of schistosomiasis patients diag-
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Table 1 Population and study sample
District Village Population Sample
n
Sambo Tongsaong Thleak 1634 72
Kampong Krabei 662 94
Ampil Teuk 1063 96
Sambo 2245 80
Subtotal 5604 342
Chhlong Chryothmar 3614 103
Total 9218 445H. Keang et al.
osed in the health facilities in the endemic area (Urbani
t al., 2002). The infection rates were monitored annually
y stool analysis of schoolchildren in four sentinel villages.
he data showed a marked decline in infection from more
han 60% to less than 3% (Ohmae et al., 2004). Health
romotion activities and the provision of safe water sources
ed to general improvements in the target communities.
verall, the intervention was very successful with regard to
nfection and severe morbidity control (Sinuon et al., 2007).
Ultrasonography is used to assess liver morbidity due
o Schistosoma infection (Richter et al., 2003). Guidelines
or standardised ultrasonographic assessment are available
WHO, 2000) and allow the evaluation of large-scale con-
rol programmes (Hatz, 2001). Periportal ﬁbrosis and portal
ypertension are the primary indicators for the disease. Thus
ltrasonography has been used to assess S. japonicum foci
Hatz et al., 1992), but only very few data are available for
. mekongi-endemic areas.
The objective of the present study conducted in 2002 was
o measure the prevalence of liver morbidity attributable to
. mekongi in the endemic area of Sambo district following
even rounds of annual mass drug administration, by com-
aring it with signs, symptoms and measures of pathology
n the non-endemic untreated area of Chhlong district. The
tudy was conducted using family histories, clinical exami-
ations and ultrasonographies.
. Materials and methods
he study was carried out in the province of Kratie
n May and June 2002. A cross-sectional sample survey
as conducted in four schistosomiasis-endemic villages of
mpil Teuk, Kampong Krabei, Tongsaong Thleak and Sambo
Table 1) in the district of Sambo (district population: 39
02 habitants in 2002), in which in 1994, during a baseline
urvey prior to control activities, a high prevalence of liver
orbidity was found (Stich et al., 1999). Households were
dentiﬁed by random selection from the list of households
rovided by the village chief. All subjects older than 14 years
nd present on the survey day were enrolled.Chryothmar village (Table 1), located on the shore of
he Mekong and capital of the Chhlong district (district
opulation in 2002: 47 919 habitants), was chosen as a
omparison. Enrolment procedures were the same as in the
ambo district.
% female Age range (years) Mean age (years)
68.1 15—69 34.8
62.8 14—55 31.2
58.3 15—53 29.1
60.0 15—55 29.3
62.0 14—69 30.9
56.3 16—63 37.0
60.7 14—69 32.3
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nSchistosoma mekongi morbidity after mass treatment in Cam
Chhlong district in the southern part of Kratie province
is only marginally affected by S. mekongi transmission. It
is considered a non-endemic area. The river ecology is pro-
foundly different. Sandy shores prevail and are unfavourable
for the development of the intermediate snail host Neotric-
ula aperta, which requires rocky underground material
(Attwood et al., 2004; Ohmae et al., 2004). Schistosoma
mekongi infections have rarely been reported in this dis-
trict and a sero-epidemiological survey, using S. japonicum
antigens, showed that fewer than 20% of the schoolchildren
tested positive (Ohmae et al., 2004). In contrast, the dis-
tricts of Sambo and Kratie had a seroprevalence of more
than 95%. Consequently, no treatment campaigns were per-
formed in Chhlong district.
All enrolled people were interviewed for a history of
haematemesis, bloody stool, abdominal pain and diarrhoea
in the past 2 weeks, family history of deaths due to
schistosomiasis and the number of treatments with prazi-
quantel. Subsequently, each subject underwent a directed
clinical examination for the presence of hepatomegaly,
splenomegaly and shunt circulation, ascites and jaundice.
Hepatomegaly was scored by palpating the left liver lobe
along the xiphoid-umbilicus line in supine position. Hep-
atomegaly was deﬁned as absent when the left liver lobe
was not palpable and as present when the left liver lobe
was palpable under the xiphoid. The presence of ascites
was assessed by percussion and ﬂuid thrill. Spleen enlarge-
ment was registered using the Hackett score (Hackett,
1944).
Liver pathology was assessed with an ultrasonographic
examination following the Niamey protocol (WHO, 2000)
by using a Fukuda Denshi UF-4000 (scan sectorial FUT-
C111A 3,5MHz 60R convex probe) portable ultrasonography
machine. We assessed the score of image patterns of the
liver parenchyma (IP score), the height-standardised score
for periportal thickening (PT score) and periportal hyper-
tension (PH score). PH score consisted of the sum of the
height-standardised portal vein diameter (portal vein score:
0, 4 or 6), the presence of collateral veins (collateral score:
0 or 4) and the presence of ascites (ascites score: 0 or 3).
The ﬁnal score consisted of the IP score, PT score and the
PH score. Liver surface, shape of the caudal liver edge and
height-standardised lengths of the right and left liver lobes
were assessed but reported independently of the scoring
results.
We aimed to enrol 82 adults per village, which allowed
for estimating a factor of unknown prevalence (P = 0.5) with
a precision of 0.15 (power 80%, alpha 0.05) at the village
level and 0.08 for all the four villages in the S. mekongi-
endemic area (n = 328). All data were entered into EpiInfo
version 6.04 (CDC, Atlanta, GA, USA). Data were analysed
with STATA version 8.2 (Stata Corp., College Station, TX,
USA). Excess risk was calculated for the S. mekongi-endemic
area by subtracting prevalence of absolute risks from the
endemic area minus the non-endemic area and exact 95%
conﬁdence intervals were calculated (95% CI ER). For data
on the portal hypertension score and the ﬁnal score of the
endemic district, an ordered logistic regression was used
to test whether age groups and gender independently con-
tribute to the observed morbidity pattern. The data were
grouped in four age groups: 14—24 years, 25—34 years,
35—44 years and 45 years and older.
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The study followed the ethical conduct deﬁned in the
uidelines of the Declaration of Helsinki (1964). All patients
ave their informed oral consent before being included in
he study.
. Results
total of 445 people was enrolled in the study (Sambo dis-
rict 342, Chhlong district 103). Details of the sample are
iven in Table 1. In Sambo district 34.2, 33.3, 18.7, 13.7
nd 1.5% fell into the 14—24, 25—34, 35—44 and 45 years
nd older age group, respectively, while in Chhlong dis-
rict 18.5, 23.3, 29.1 and 29.1% of the subjects were in the
espective age groups. The median age in Sambo district
as 30 years, signiﬁcantly younger than in Chhlong district
37 years, P < 0.001). There was no difference in mean age
etween the sexes, or sex ratio between the two districts
P = 0.3).
The socio-economic status of the examined population
f Sambo was signiﬁcantly lower than Chhlong district. A
igniﬁcantly smaller proportion of the study participants in
ambo district attended secondary school (14.6 vs. 33.0%,
< 0.001, controlled for age group). Most of the studied
ambo population were rice farmers, whereas this activity
as rare in the studied village of Chhlong district (79.8 vs.
.7%).
Clinical examination revealed schistosomiasis-related
orbidity in Sambo district (Table 2). Hepatomegaly
24.3%), splenomegaly (54.7%) and clinical signs of portal
ypertension such as ascites (1.2%) and collateral veins
2.0%) were seen only in people in the schistosomiasis-
ndemic district. Jaundice was diagnosed in three patients
1.2%). Blood in stool and abdominal pain was reported
igniﬁcantly more often in Sambo than in Chhlong district
P < 0.001), while no difference was recorded for diarrhoea.
Twelve per cent of people in the district of Sambo
eported to have lost at least one family member due to
chistosomiasis in recent years compared with no reports in
he non-endemic district of Chhlong.
In Sambo district, at least three treatments with prazi-
uantel during mass drug administration were reported by
2.5% of the people and 21.9% reported to have been treated
ix or seven times. No treatment reports were recorded in
hhlong district.
Ultrasonographic investigations revealed major liver
athology in the schistosomiasis-endemic district of Sambo,
hile very little pathology was found in Chhlong district
Table 3). In almost half the examined subjects (45.5%), we
iagnosed advanced periportal ﬁbrosis with portal hyper-
ension. In Sambo district, more than one-ﬁfth of the
ubjects (23.1%) had moderate or severe portal hyperten-
ion (PH score) and periportal vein thickening was prevalent.
n Sambo, 40% of subjects showed highly echogenic ruff
reas around the portal bifurcation and the main stems
f the liver parenchyma. In addition, we frequently diag-
osed severe ﬁbrotic liver parenchyma, consisting of high
chogenic patches extending from the main portal vein and
ranches into the parenchyma (23% of subjects). No reticular
atterns of liver morbidity were identiﬁed.
Analysis of the liver morbidity scores in Sambo dis-
rict revealed a similar pattern in all villages and in both
762 H. Keang et al.
Table 2 Results of the history and clinical examination of 445 study participants
Sambo (n = 342) % Chhlong (n = 103) % Excess risk in endemic area
% 95% CI
History
Haematemesis 5.9 1.0 4.8 1.8—8.0
Blood in stool (past 2 weeks)a 40.6 20.4 20.2 10.9—29.6
Abdominal pain (past 2 weeks)a 77.5 57.3 20.2 9.7—30.7
Diarrhoea (past 2 weeks)b 44.4 35.9 8.5 2.1—19.2
Family death due to schistosomiasis
None 88.0 100 — —
1 person 7.6 0 7.6 4.8—10.4
2 or 3 people 4.4 0 4 2.2—6.6
Praziquantel treatment
0 7.0 100 — —
1—2 times 30.4 0 30.4 25.5—35.3
3—5 times 40.6 0 40.6 35.4—45.8
6—7 times 21.9 0 21.9 17.5—26.3
Clinical examination
Hepatomegaly (present) 24.3 0 — 19.7—28.8
Splenomegaly (Hackett score)c
0 45.3 100 — —
1 12.6 0 12.6 9.1—16.1
2—3 32.1 0 32.1 27.2—37.1
4—5 9.9 0 9.9 6.8—13.1
Ascites (present) 1.2 0 1.2 0.03—2.3
Collateral veins (present) 2.0 0 2.0 0.5—3.5
Jaundice (present) 1.2 0 1.2 0.03—2.3
a Signiﬁcant difference between districts at P < 0.001, controlled for age.
b Signiﬁcant difference between districts at P < 0.05, controlled for age.
c See Hackett (1944).
Figure 1 (A) Final score of ultrasonography assessment by age in Sambo district (n = 342; PF: periportal ﬁbrosis; APF: advanced
PF; PH: portal hypertension). (B) Portal hypertension (PH) score by age in schistosomiasis-endemic district of Sambo (n = 342).
Schistosoma mekongi morbidity after mass treatment in Cambodia 763
Table 3 Results of ultrasonographic examinations in Sambo and Chhlong districts
Sambo (n = 342) % Chhlong (n = 103) % Excess risk in endemic area
% 95% CI
Final scorea
No PF 11.2 99.0 —
PF possible 37.3 1.0 36.2 30.5—40.9
PF conﬁrmed 1.0 0 1.0 0.1—2.0
APF 5.1 0 5.1 2.7—7.5
APF + portal hypertension 45.5 0 45.5 40.0—50.0
PH score (grouped)
0 normal 50.0 95.1 — —
4 light 26.9 4.9 22.0 15.8—28.3
6—8 moderate 17.8 0 17.8 13.8—21.9
10—13 severe 5.3 0 5.3 2.9—7.6
PT score
0 normal 0.9 1.9 — —
1 slightly increased 86.6 98.1 — —
4 increased 10.2 0 10.2 7.0—13.4
8 much increased 2.3 0 2.3 0.7—3.9
IP scoreb
0 0.9 1.9 — —
1 10.8 97.1 — —
2 24.6 1.0 23.6 18.7—28.5
4 39.5 0 39.5 34.3—44.7
6 22.5 0 22.5 18.1—26.9
8 1.8 0 1.8 0.4—3.1
Liver surface (frontal)
Regular 6.4 98.1 — —
Lightly nodular 74.0 1.9 72.0 66.7—77.4
Nodular 19.6 0 19.6 15.4—23.8
PF: periportal ﬁbrosis; APF: advanced PF; PH: portal hypertension; PT: periportal vein thickening; IP: image pattern.
a n = 412 (92.6% of total); for 33 patients ﬁnal score could not be established.
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sb Short description of IP score: 0, normal; 1, diffuse foci; 2, rin
patches extending from main portal vein and branches to parenc
bifurcation to liver surface.
sexes. However, substantial age differences were observed.
The population between 25 and 34 years of age was
mostly affected. Of them, 61.0 and 64.4% suffered from
advanced periportal ﬁbrosis with portal hypertension and
portal hypertension, respectively, while in other age groups
corresponding rates were much lower (Figure 1).
Ordered multiple regression analysis showed that age
group rather than gender contributes to the advanced peri-
portal ﬁbrosis and portal hypertension. Subjects aged 25 to
34 had a 1.75-fold risk of an increased ﬁnal score compared
with the youngest age group, controlled for sex and age
group (95% CI 1.04—2.94, P = 0.033). Similar results were
obtained for the portal hypertension score. Subjects aged
25 to 34 years had double the risk for portal hypertension
compared with the youngest age group, controlled for sex
and age group (OR = 2.02, 95% CI 1.24—3.29, P = 0.005). The
risks for portal hypertension for the older age groups were
not signiﬁcantly different from those of the 14—24 year olds
(OR = 0.76, 95% CI 0.42—1.38, P = 0.368 and OR= 0.64, 95%
CI 0.33—1.24, P = 0.187 for subjects aged 35—44 and 45—69
years, respectively).
a
g
w
g
does; 4, ruff zones around portal bifurcation and main stem; 6,
; 8, bands and streaks extending from main portal vein and its
. Discussion
ur study reveals a high degree of sub-clinical liver mor-
idity, reaching a prevalence of more than 60% of advanced
eriportal ﬁbrosis and portal hypertension in young adults
aged 25—34 years) in the district of Sambo, Kratie´ Province,
ambodia. Younger and older age groups were also affected,
ut substantially less so. Furthermore, very little liver
athology could be detected in the district of Chhlong, sug-
esting that the observed morbidity in Sambo district was
n excess morbidity attributable to S. mekongi infections.
In 1995, in Sambo district, left liver lobe enlargement
as clinically observed in high frequencies in the commu-
ities (Biays et al., 1999). In the hospitals of this province
hese observations were conﬁrmed. Furthermore, the con-
equences of severe portal hypertension, such as ascites
nd oesophageal bleeding, were frequent and led to a
reat number of casualties. In 1998, 106 chronic patients
ith portal hypertension were identiﬁed. Eleven were eli-
ible for surgical decompression procedures in order to
ecrease portal hypertension (Dumurgier et al., 2006).
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istological liver examinations of six of these patients
evealed a surprisingly high degree of ﬁbrosis (Monchy et
l., 2006). No similar observations were made in the Chhlong
istrict.
Sub-clinical liver morbidity could not be assessed in 1995.
herefore, no data are available for a direct comparison
ith our study. However, an ulrasonographic assessment was
erformed in 1997 in a S. mekongi-endemic village in the
tung Treng province (north of Kratie province). Of 223 sub-
ects, 73% were found positive for S. mekongi, and periportal
hickening and/or portal vein enlargement was diagnosed
n 84% (Urbani et al., 2002). Therefore, it is reasonable to
ssume that sub-clinical morbidity was present in compara-
le frequencies for 1995 in the Kratie province.
Undoubtedly, between 1994 and 2002, the situation has
uch improved in terms of infection and morbidity (Sinuon
t al., 2007). The prevalence of clinically observed hep-
tomegaly has dropped from over 60% to an undetectable
evel in annually examined sentinel primary schools (Ohmae
t al., 2004). Our study diagnosed hepatomegaly in 25% of
ur subjects. In 1994, in comparable age groups, more than
0% had the same ﬁnding.
Based on the high number of mass drug administrations
e assumed that most S. mekongi infections were cured.
onsequently, the question arises whether the observed sub-
linical liver morbidity is indeed a residual part of the S.
ekongi infection-induced pathology in the population, or
rovoked by other factors such as hepatitis B (HBV) and
(HCV) infections. Hepatitis infections may lead to hep-
tic reticular lesions of similar ultrasonographic appearance
Kardorff et al., 1999). As a community survey in 1991 indi-
ated that 8.0% of the Cambodian population was hepatitis
surface antigen positive and 6.5% was anti-HCV positive
Thuring et al., 1993), these infections could have poten-
ially contributed to our morbidity ﬁndings. Furthermore,
ambodia has one of the world’s highest overall injection
sages (Vong et al., 2005), suggesting a high rate of overuse
nd unsafe injection practices, which may lead to these
nfections. Therefore, a contribution of hepatitis viruses
o the observed liver morbidity cannot be excluded. How-
ver, we believe that a major part of this liver pathology
s attributable to S. mekongi infection, for the following
easons.
Firstly, we observed liver pathology in a high preva-
ence of 46%. In 1998, in an attempt to select chronic
chistosomiasis patients for surgical treatment, 106 severe
chistosomiasis cases were examined, 30% of whom were
ound positive for HBV or HCV antigen (19% HBV, 9% HCV,
% both; Dr Muth Sinuon, National Malaria Centre, Phnom
enh, personal communication). In a sample of 421 individ-
als in Kratie province, Chigusa and colleagues found 20.2%
ositive HBV (Chigusa et al., 2006). Such a prevalence could
e expected in our study population. But most probably it
as lower because subjects in our study were not sick and
herefore had less frequent contact with a health facility
ompared with the chronic severe cases of schistosomiasis.
ence, our study population was at lower risk for hepatitis
nfection.
Secondly, hepatitis infections provoke hepatic reticular
esions, mainly at the late stage of the disease. Therefore,
ne would expect to ﬁnd liver pathology in older individuals.
owever, in our study we found pathology predominantly
g
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eH. Keang et al.
n young adults (aged 25—34 years) and adolescents (aged
4—24 years).
Thirdly, a 2-year cohort study of liver morbidity due to
. japonicum showed that after a single treatment with
raziquantel, sub-clinical liver morbidity was signiﬁcantly
educed (Li et al., 2000), but even after 5 years follow-
p the resolution was not complete (Li et al., 2002). It
as concluded that pathological changes around the por-
al tree might regress to a large degree but that ‘network
attern’ abnormalities do not normally resolve (Richter,
000). A comparable ﬁnding was obtained in a 2-year cohort
tudy in Stung Treng province in Cambodia for S. mekongi
etween 1997 and 1999 (Hatz, 2001). While at the start of
he cohort only 18.1% of subjects had a normal liver ultra-
onographic assessment (pattern A or B of Niamey protocol),
fter 2 years 81.6% did not reveal pathological liver lesions
Urbani et al., 2002). But, in all patients, the resolution
f liver morbidity was incomplete. Based on these ﬁndings,
iver pathology is to be expected in the S. mekongi-endemic
reas.
Finally, very little pathological ﬁnding was found in Chh-
ong district, where S. mekongi is rare. We would expect
hat with a high rate of injection drug use, and a resulting
igh risk for hepatitis, at least some hepatic lesions should
ave been found. This, however, was not the case.
A surprising ﬁnding was that a substantial number of
ubjects in Chhlong district reported blood in stool. Sero-
ogical studies showed that some infections with S. mekongi
ere present in this district, which explains these reports to
ome extent (Ohmae et al., 2004). In addition, other infec-
ions, such as by Strongyloides spp., might have contributed
o the observation. Furthermore, mis-reporting cannot be
xcluded.
Our study followed the recommendations on the mor-
idity assessment procedures for Asian schistosomiasis
stablished by WHO expert committee in Phnom Penh
Cambodia, 2002) and Yueyang (Hunan Province, China,
005) (WHO, 2007). The study suffers from epidemiolog-
cal weaknesses. The sampling procedures resulted in a
emale-dominated sample population, as many men were
way in the rice ﬁelds. The sample was not proportional to
he population size, and no information could be obtained
rom non-participating individuals. Furthermore, the dis-
ricts could not be matched for other prognostic variables.
hese factors limit the strength of the conclusions that can
e drawn about the general population. In addition, due to
ack of resources we were not able to perform laboratory
nvestigations such as stool examinations for S. mekongi and
erological analysis for hepatitis virus infection.
Nonetheless, our study demonstrates that a substan-
ial amount of sub-clinical morbidity is present in a
chistosomiasis-endemic district, which was probably to a
arge extent residual morbidity due to S. mekongi. The
trength of our study is that we included a control group
rom a non-endemic district and demonstrated the amount
f sub-clinical morbidity in a community where little active
. mekongi infection is present. It furthermore showed that
ross clinical morbidity was rare, providing further evidence
or a successful intervention. Careful follow-up and moni-
oring are required, and necessary action needs to be taken
o maintain and consolidate gains from preceding control
fforts.
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